GGrantIndex
Sort

17,054 grants matching genome editing

A Resource Center for Tetrahymena Thermophila

$218,648
Theodore G Clark · Cornell University · P40 · FY2021 · OD

Connecting the gap between GWAS and functional targets for lupus susceptibility

$218,500
Swapan K Nath · Oklahoma Medical Research Foundation · R21 · FY2023 · AI

Role of Two Interferon Regulatory Genes in Lupus

$218,500
Swapan K Nath · Oklahoma Medical Research Foundation · R21 · FY2020 · AI

Methods for mammalian genetic analysis

$218,285
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Core B: The Cell Culture Core

$218,261
Karen M Ridge · Northwestern University At Chicago · P01 · FY2020 · GM

Correction of endocrine disruptor-induced transgenerational epimutations by CRISPR-dCas9

$218,250
Ramji Kumar Bhandari · University Of North Carolina Greensboro · R21 · FY2020 · HD

A Molecular Grammar for Guide RNAs (gRNAs) with Engineered Secondary Structures

$218,250
Yirong Mo · University Of North Carolina Greensboro · R21 · FY2023 · EB

Conserved AHR-dependent control of Sox9 long non coding RNA expression

$218,149
Robert L Tanguay · Oregon State University · R21 · FY2015 · ES

Next generation of delivery platform for Prime editors based on an RNA vector for Sickle cell disease: the “all-in-one” vector

$217,890
Patricia Devaux · Mayo Clinic Rochester · R21 · FY2024 · EB

Bioinformatics Discovery of Anti-CRISPR Operons in Human Gut Microbiome

$217,788
Yanbin Yin · University Of Nebraska Lincoln · R21 · FY2022 · AI

Novel inhibitors of oncogenic p53 mutants for lung cancer therapy.

$217,738
Swati P Deb · Virginia Commonwealth University · R21 · FY2023 · CA

Role of the DREAM complex in the lung tumor suppression

$217,738
Larisa Litovchick · Virginia Commonwealth University · R21 · FY2023 · CA

Molecular mode of action of Juvenile hormone analogs

$217,500
Subba R Palli · University Of Kentucky · R21 · FY2021 · AI

Towards The Therapeutic Implementation of New CRISPR-Cas Systems

$217,484
Niles Patrick Donegan · Excision Biotherapeutics, Inc. · R43 · FY2019 · GM

Development of A Directed Evolution Platform for RNA Methyltransferases.

$217,388
Huiqing Zhou · Boston College · R61 · FY2024 · CA

Development of A Directed Evolution Platform for RNA Methyltransferases.

$217,388
Huiqing Zhou · Boston College · R61 · FY2025 · CA

Core B: The Cell Culture Core

$217,340
Karen M Ridge · Northwestern University At Chicago · P01 · FY2019 · GM

Administrative Core

$217,207
Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2025 · AI

Development of transgenic protocols for the Lyme disease vector, Ixodes scapularis, for tick and tick-borne disease control

$217,008
Monika Gulia-Nuss · University Of Nevada Reno · R21 · FY2019 · AI

Molecular genetic mechanisms of opioid receptor signaling

$216,882
Brock Grill · Scripps Florida · R01 · FY2020 · DA

Methods and Analysis

$216,733
Eve Van Cauter · Northwestern University At Chicago · P01 · FY2017 · AG

Project 1 - TBD

$216,646
Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2024 · GM

Prioritizing autoimmune-associated genetic variants that alter regulatory element activity in B cells

$216,625
John Philip Ray · Benaroya Research Inst At Virginia Mason · R21 · FY2023 · AI

T Cell Epigenomic Drivers of Disease Flares in Multiple Sclerosis

$216,625
Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R21 · FY2025 · AI

Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium

$216,547
Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2016 · DK